354 related articles for article (PubMed ID: 36082064)
41. Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Katsuura T; Kitajima K; Fujiwara M; Terada T; Uwa N; Noguchi K; Doi H; Tamaki Y; Yoshida R; Tsuchitani T; Fujita M; Yamakado K
Ann Nucl Med; 2018 Aug; 32(7):453-462. PubMed ID: 29858797
[TBL] [Abstract][Full Text] [Related]
42. The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
Inohara H; Enomoto K; Tomiyama Y; Yoshii T; Osaki Y; Higuchi I; Inoue T; Hatazawa J
Acta Otolaryngol; 2009 Aug; 129(8):893-9. PubMed ID: 18839385
[TBL] [Abstract][Full Text] [Related]
43. Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.
Wiedenmann N; Bunea H; Rischke HC; Bunea A; Majerus L; Bielak L; Protopopov A; Ludwig U; Büchert M; Stoykow C; Nicolay NH; Weber WA; Mix M; Meyer PT; Hennig J; Bock M; Grosu AL
Radiat Oncol; 2018 Aug; 13(1):159. PubMed ID: 30157883
[TBL] [Abstract][Full Text] [Related]
44. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
[TBL] [Abstract][Full Text] [Related]
45. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
46. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273
[TBL] [Abstract][Full Text] [Related]
47. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
[TBL] [Abstract][Full Text] [Related]
48. [
Ferrari C; Santo G; Mammucci P; Rubini D; Sciacqua A; Sardaro A; Pisani AR; Rubini G
BMC Med Imaging; 2023 Feb; 23(1):34. PubMed ID: 36814217
[TBL] [Abstract][Full Text] [Related]
49. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.
Ong SC; Schöder H; Lee NY; Patel SG; Carlson D; Fury M; Pfister DG; Shah JP; Larson SM; Kraus DH
J Nucl Med; 2008 Apr; 49(4):532-40. PubMed ID: 18344440
[TBL] [Abstract][Full Text] [Related]
50. Post-treatment
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2020 Aug; 107():104750. PubMed ID: 32361565
[TBL] [Abstract][Full Text] [Related]
51. Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study.
Helsen N; Van den Wyngaert T; Carp L; De Bree R; VanderVeken OM; De Geeter F; Maes A; Cambier JP; Spaepen K; Martens M; Hakim S; Beels L; Hoekstra OS; Van den Weyngaert D; Stroobants S; ; Van Laer C; Specenier P; Maes A; Debruyne P; Hutsebaut I; Van Dinter J; Homans F; Goethals L; Lenssen O; Deben K
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1075-1082. PubMed ID: 32040611
[TBL] [Abstract][Full Text] [Related]
52. Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
Prestwich RJ; Subesinghe M; Gilbert A; Chowdhury FU; Sen M; Scarsbrook AF
Clin Radiol; 2012 Oct; 67(10):966-75. PubMed ID: 22595082
[TBL] [Abstract][Full Text] [Related]
53. The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.
Matoba M; Tuji H; Shimode Y; Kondo T; Oota K; Tonami H
Br J Radiol; 2017 Mar; 90(1071):20150404. PubMed ID: 28055245
[TBL] [Abstract][Full Text] [Related]
54. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of clinical and
Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
[TBL] [Abstract][Full Text] [Related]
56. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
57. Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Castaldi P; Rufini V; Bussu F; Miccichè F; Dinapoli N; Autorino R; Lago M; De Corso E; Almadori G; Galli J; Paludetti G; Giordano A; Valentini V
Radiother Oncol; 2012 Apr; 103(1):63-8. PubMed ID: 22459579
[TBL] [Abstract][Full Text] [Related]
58. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
[TBL] [Abstract][Full Text] [Related]
59. Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
Zhou S; Rulach R; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Lau YC; Paterson C
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):665-673. PubMed ID: 32561027
[TBL] [Abstract][Full Text] [Related]
60. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
